All News

Do you use Otezla with biologics in PsA? #RNL2022 @RheumNow

Dr. Rachel Tate uptoTate ( View Tweet)

IL-17i - Good Long term safety profile and low malignancy risk Best efficacy for nail psoriasis @RheumNow #RNL2022 https://t.co/8T7wAGJChF
Robert B Chao, MD doctorRBC ( View Tweet)
"The most important thing to consider is what is the risk of PsO on the overall health (of the patient.)" BSA > 10% showed increase all cause mortality rates in IHOPE study. Dr. K. Gordon discusses PsO treatment complexity and importance at #RNL2022 @RheumNow https://t.co/ouHPbLmlqD
Dr. Rachel Tate uptoTate ( View Tweet)
Have you seen the MTX data regarding PsO? Dr. Gordon reviews the METOP data. My take homes: MTX has moderate efficacy and takes a long time! #RNL2022 @RheumNow https://t.co/B28onPUKn8
Dr. Rachel Tate uptoTate ( View Tweet)
Excellent charts presented by Dr. Kenneth Gordon on the PASI response and QoL response amongst different PsO therapies @RheumNow #RNL2022 https://t.co/e3gqcPzk79
Robert B Chao, MD doctorRBC ( View Tweet)
How to treat #psoriasis #PsO Indivualize for pt. OK to try more than one drug within a class if initial fails or isn’t tolerated. Common I think to have 2ndary loss of response even with dose escalation. Skin is sneaky immunologically! #RNL2022 @RheumNow https://t.co/pFPNCVLSvk
Janet Pope Janetbirdope ( View Tweet)
#ClinicalPearl Fun fact According to Dr Strober IL17i have BEST effects on nail involvement in #psoriasis. I didn’t know. often need ⬆️dose over time #RNL2022 @RheumNow https://t.co/Y9U9c4M03j
Janet Pope Janetbirdope ( View Tweet)
Current treatment paradigm for PsO @RheumNow #RNL2022 https://t.co/yDc3Pk0RjI
Robert B Chao, MD doctorRBC ( View Tweet)
Great feedback on @Janetbirdope presentation. #RNL2022 “thank you so much Dr. Pope. wish you had more time because the presentation was so applicable to clinical practice” We are so glad you enjoyed!

Dr. John Cush RheumNow ( View Tweet)

ACPA is a strong predictor for RA development. any ACPA : 30% developed RA within 3 years. High titer ACPA: 50% developed RA with 3 years. Finally ACPA Titer Matters?! @karen_kc123 @RheumNow #RNL2022 https://t.co/blbVovf1KZ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Healthy behaviors (moderate EtOH, healthy body weight, no smoking, healthy diet, physical activity) associated with lower RA risk "Chronic systemic inflammation fans the flames of brewing RA" @RheumNow #RNL2022 https://t.co/gAerZaAcso
Robert B Chao, MD doctorRBC ( View Tweet)
Family history risk includes genetic and shared environmental factors @RheumNow #RNL2022 https://t.co/3J4nisbSX1
Robert B Chao, MD doctorRBC ( View Tweet)
ACPA prior to RA diagnosis. Notice epitope spreading proceeding diagnosis!! @karen_kc123 @RheumNow #RNL2022 https://t.co/glgrOdVyyJ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Completed Early RA prevention trials using agents like steroids, RTX, atorvastatin, abatacept No sig difference in steroids, atorvastatin RTX delayed onset but no overall diff Abatacept decreased RA progression at 1.5 years @RheumNow #RNL2022 https://t.co/v7WxI2P7r5
Robert B Chao, MD doctorRBC ( View Tweet)
Top Influencers of #RNL2022: @RheumNow @uptoTate @Janetbirdope @NoufAhmedAlham2 @doctorRBC @hausmannMD More 📊 https://t.co/5tIzMLfqrh

Links:

Symplur Hashtags healthhashtags ( View Tweet)

@Janetbirdope on drug cycling in #RA. What’s beyond TNFi failure? No golden rule, but: 👉🏻 switching to non-TNF can be superior than staying with the TNFi class 👉🏻 response to other bDMARs maybe blunted in non-TNFi naive 👉🏻 JAKi can be a good choice for some @RheumNow #RNL2022 https://t.co/25MiiFh2CK
Elena MyasoedovaMD MyasoedovaElena ( View Tweet)
How NOT to get rheumatoid arthritis. Excellent tips by @karen_kc123 #RNL2022 #rheumatoidarthritis https://t.co/brLeWzioQD
Jonathan Hausmann MD hausmannMD ( View Tweet)
Patients often ask me what they can do on their part to help their disease... this is it! @karen_kc123 reviews the modifable risks in RA. @rheumnow #RNL2022 @CreakyJoints https://t.co/FM0BtNX6eb
TheDaoIndex KDAO2011 ( View Tweet)
#Rheumatoid arthritis- is it all or partially in your genes 🧬? Many genes are not sufficient or necessary to produce #RA. Genes were used in a study to predict development of RA better than clinical parameters. But not ready for prime time YET #RNL2022 @RheumNow @karen_kc123 https://t.co/J5aBs4iLbR
Janet Pope Janetbirdope ( View Tweet)
Dr. Elena Myasoedova on Multimorbidities and RA Important to recognize multimorbities are 2-3x higher in RA and how it impacts our RA pts @RheumNow #RNL2022 https://t.co/N6VPdU6wzV
Robert B Chao, MD doctorRBC ( View Tweet)
×